Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis.
about
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationPrimate aging in the mammalian scheme: the puzzle of extreme variation in brain agingGenetic variants associated with neurodegenerative Alzheimer disease in natural modelsBrain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeuticThe cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activityCysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeuticsGenetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor proteinDeletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's diseaseThe Rps23rg gene family originated through retroposition of the ribosomal protein s23 mRNA and encodes proteins that decrease Alzheimer's beta-amyloid level and tau phosphorylationA functional mouse retroposed gene Rps23r1 reduces Alzheimer's beta-amyloid levels and tau phosphorylationNoninvasive peroneal sensory and motor nerve conduction recordings in the rabbit distal hindlimb: feasibility, variability and neuropathy measureCharacterization of Amyloid-β Deposits in Bovine BrainsImplications of protein structure instability: from physiological to pathological secondary structure.Rhinal and dorsolateral prefrontal cortex lesions produce selective impairments in object and spatial learning and memory in caninesA combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes.Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines.Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampusLeptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slicesβ-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathwayCholesterol and copper affect learning and memory in the rabbit.Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard catsLong-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Aging in the canine and feline brainMolecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus.Neurobiology of the aging dog.Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice.Amyloid-β-induced amyloid-β secretion: a possible feed-forward mechanism in Alzheimer's Disease.Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic miceRoles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's diseaseThe domestic cat as a natural animal model of Alzheimer's disease.Oxidative stress, aging, and central nervous system disease in the canine model of human brain agingComputational Prediction of Alzheimer's and Parkinson's Disease MicroRNAs in Domestic AnimalsCombining an antioxidant-fortified diet with behavioral enrichment leads to cognitive improvement and reduced brain pathology in aging canines: strategies for healthy aging.Impairment of context memory by beta-amyloid peptide in terrestrial snailAlternative pathways for production of beta-amyloid peptides of Alzheimer's disease.Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.
P2860
Q26823454-C92EA159-A9E1-4192-BD04-A22869BF22E4Q26865145-C99003DB-E1FD-4680-8951-32DD272022D4Q28079843-6366C5BF-D50B-4600-BEF5-BD5E564C450BQ28235248-B7117A1D-4998-4835-B529-7F0D448C090EQ28238581-37D3BB6E-E4FC-4B61-B171-6A3DCDD164CEQ28240590-6E748D10-6FC7-4876-BC02-54EC3455328CQ28247574-EB022F3F-5765-4D12-AEAF-C59AC0A04E99Q28259920-56ABB57E-F174-40DC-B727-A87804F978A4Q28285644-81DAD54F-57B7-466A-B4D6-2DC249D637F6Q28506412-3CB75174-C724-4B75-B5C4-3648311AEFEAQ28507501-649E5C02-6D29-4214-85DC-C523C72C69B0Q28541336-936A6165-4A2E-47A8-A235-C2F21B2E5BA8Q28597085-B1D583B0-137B-4538-923F-26E73622AF5DQ30416896-33C50DA5-7924-47C7-9DD4-F92A07EABBABQ30434524-89614034-E6C7-4BB2-9FF8-85952C8DE3ABQ33552777-DD3D16EF-0685-4D17-A244-9FA588115339Q33863439-70935964-B65C-44A9-B712-9088124B6261Q33993315-9A2A9237-01B2-4756-910D-FC2C3D224AB0Q34064442-83208F6E-E6D8-490F-9D34-59679F5FB0C4Q34075070-9A9C4979-9CB3-4387-A4FD-A7862A628085Q34267894-DEBF6F55-F1B8-4FB8-BD47-48CFD92C2A10Q34373769-54A4AC7E-EBDA-4191-9AFD-4844FEF4F3CEQ34441477-1D44914A-EE6E-43E6-B908-1C667DCD586FQ34556705-0F11CB3A-B5FE-4516-9EBB-19E99C53BF57Q34625739-CF533221-AE60-4407-877F-F45329481072Q35063700-7A1F3DEF-0AC0-4AA2-8A81-7E6451AF648FQ35201102-62125A66-D770-49D9-BA67-0FF58F2B9A61Q35225919-156C78C4-E82A-4086-8050-F008E2F74EA1Q35619312-7CBC89AE-C47E-4FEB-8190-FE45D4D206DDQ35659998-BD6B897C-50F6-42D9-AADE-6F35ED3B2A38Q35747037-D417B3D7-5633-4C53-A16C-1AFBDB5E8D87Q36076365-B2D57D3D-D89A-450F-A879-BE21931E7C6AQ36187149-D48E294F-4964-4BA5-B4B5-869CEDA96575Q36361410-B9F3F48C-4968-4B4B-90E2-7EE6E0D7E0B4Q36666206-F4C7106C-EDF0-44C6-8FE3-7313DA7BAC00Q36855169-452A7866-1077-4E18-B0F8-5CA863DAA91CQ36918473-CBB51619-A46E-4B73-AED1-3A45CBBD9187Q36936100-F03DBD6D-4834-4A7A-9F37-23D890A3391CQ37124928-5859BB20-A6FE-4AE1-B283-E08440D4ABC3Q37324557-C977099E-90DE-4A31-8A43-4B45995FCD1D
P2860
Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Conservation of the sequence o ...... erase chain reaction analysis.
@en
Conservation of the sequence o ...... erase chain reaction analysis.
@nl
type
label
Conservation of the sequence o ...... erase chain reaction analysis.
@en
Conservation of the sequence o ...... erase chain reaction analysis.
@nl
prefLabel
Conservation of the sequence o ...... erase chain reaction analysis.
@en
Conservation of the sequence o ...... erase chain reaction analysis.
@nl
P2093
P1476
Conservation of the sequence o ...... erase chain reaction analysis.
@en
P2093
P304
P356
10.1016/0169-328X(91)90088-F
P577
1991-07-01T00:00:00Z